| Dr Jennifer Clark, PSYD | |
|
19000 Homestead Rd, Bldg. 2, Floor 1, Cupertino, CA 95014-0712 | |
| (408) 366-4463 | |
| Not Available |
| Full Name | Dr Jennifer Clark |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 19000 Homestead Rd, Cupertino, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396289666 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 28626 (California) | Primary |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.
The first laser treatments used to treat skin conditions such as benign vascular birthmarks and port-wine stains were developed more than 40 years ago. Since then, clinicians and dermatologists have seen a rise in demand for minimally invasive laser-based treatments, including tattoo removal.
RESEARCHERS have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to guide treatments to the cancer, according to new research presented at the National Cancer Research Institute Cancer Conference in Liverpool.
Algeta ASA has announced that with the results of the BC1-04 study reported today it has completed its comprehensive phase II clinical program evaluating Alpharadin (radium-223) as a new treatment for bone metastases in patients with hormone-refractory prostate cancer (HRPC).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Clark, PSYD 19000 Homestead Rd, Bldg. 2, Floor 1, Cupertino, CA 95014-0712 Ph: (408) 366-4463 | Dr Jennifer Clark, PSYD 19000 Homestead Rd, Bldg. 2, Floor 1, Cupertino, CA 95014-0712 Ph: (408) 366-4463 |
News Archive
Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.
The first laser treatments used to treat skin conditions such as benign vascular birthmarks and port-wine stains were developed more than 40 years ago. Since then, clinicians and dermatologists have seen a rise in demand for minimally invasive laser-based treatments, including tattoo removal.
RESEARCHERS have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to guide treatments to the cancer, according to new research presented at the National Cancer Research Institute Cancer Conference in Liverpool.
Algeta ASA has announced that with the results of the BC1-04 study reported today it has completed its comprehensive phase II clinical program evaluating Alpharadin (radium-223) as a new treatment for bone metastases in patients with hormone-refractory prostate cancer (HRPC).
› Verified 2 days ago
Dr. Roger Johnson, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 19000 Homestead Rd, Cupertino, CA 95014 Phone: 408-366-4408 Fax: 408-366-4405 | |
Dr. Steven Aldo Del Chiaro, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 20833 Stevens Creek Blvd Suite 100, Cupertino, CA 95014 Phone: 408-342-0160 | |
Dr. Helen Tait, PH.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 20395 Pacifica Dr Ste 101, Cupertino, CA 95014 Phone: 408-725-8043 Fax: 408-725-8063 | |
Dr. Julia Beth Hadricky, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 19000 Homestead Rd, Cupertino, CA 95014 Phone: 813-382-4844 | |
Priya Mahurkar, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 20833 Stevens Creek Blvd, Suite 100, Cupertino, CA 95014 Phone: 408-342-0612 Fax: 408-342-0617 | |
Dr. Catherine Mary Marino, PSY.D. Psychologist Medicare: Medicare Enrolled Practice Location: 19000 Homestead Rd, Building 2, Psychiatry Administration Suite, Cupertino, CA 95014 Phone: 650-283-9334 | |
Dr. Martin Howard Williams, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 19000 Homestead Rd, Cupertino, CA 95014 Phone: 408-366-4409 |